Evaluation of the Efficacy of Permanent Course Combined Therapy with CYTOFLAVIN® Intravenous Solution and CYTOFLAVIN Tablets, At 2-3 Stages of Rehabilitation of Patients with Post Intensive Care Syndrome
- Conditions
- Ischemic Stroke
- First Posted Date
- 2024-12-16
- Last Posted Date
- 2024-12-16
- Target Recruit Count
- 90
- Registration Number
- NCT06735898
- Locations
- 🇷🇺
Brain Institute Clinic, Ekaterinburg, Sverdlovsk region, Russian Federation
Observational Study of Efficiency of Cytoflavin, in Patients With Ischemic Stroke Not Receiving Reperfusion Therapy
- Conditions
- Stroke, AcuteStroke, Ischemic
- Interventions
- Drug: Cytoflavin
- First Posted Date
- 2024-07-23
- Last Posted Date
- 2024-07-23
- Target Recruit Count
- 562
- Registration Number
- NCT06514976
- Locations
- 🇷🇺
City Mariinsky Hospital, Saint Petersburg, Russian Federation
🇷🇺Alexandrovskaya hospital, Saint Petersburg, Russian Federation
🇷🇺"Ivanovo Regional Clinical Hospital", Ivanovo, Russian Federation
Study of Safety and Efficacy of the Drug Cycloferone in Patients with Acute Respiratory Viral Infection
- Conditions
- Acute Respiratory Viral Infection
- Interventions
- Drug: Cycloferone
- First Posted Date
- 2024-02-29
- Last Posted Date
- 2024-12-16
- Target Recruit Count
- 742
- Registration Number
- NCT06286254
- Locations
- 🇷🇺
Сity clinic No. 44, Saint Petersburg, Russian Federation
🇷🇺Medical Center Energiya Zdoroviy, Saint Petersburg, Russian Federation
🇷🇺Medical Center Oris, Saint Petersburg, Russian Federation
Comparative Study of REMAXA®, Enteric-coated Tablets and REMAXOL®, Solution for Infusions, in Intrahepatic Cholestasis
- Conditions
- Cholestasis, Intrahepatic
- Interventions
- Drug: Remaxa, enteric-coated tabletsDrug: RemaxolDrug: Placebo
- First Posted Date
- 2023-12-27
- Last Posted Date
- 2023-12-27
- Target Recruit Count
- 414
- Registration Number
- NCT06183242
- Locations
- 🇷🇺
Medical Company "Hepatologist" Ltd., Samara, Russian Federation
🇷🇺City Hospital of the Holy Martyr Elizabeth, Saint-Petersburg, Russian Federation
🇷🇺Research Center for Eco-safety, Ltd., Saint Petersburg, Russian Federation
Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza
- Conditions
- InfluenzaAcute Respiratory Infection
- Interventions
- Drug: CycloferonDrug: Placebo
- First Posted Date
- 2023-12-27
- Last Posted Date
- 2024-02-05
- Target Recruit Count
- 578
- Registration Number
- NCT06183229
- Locations
- 🇷🇺
City Outpatient Clinic #117, Saint-Petersburg, Russian Federation
🇷🇺Research Center for Eco-safety, Ltd., Saint Petersburg, Russian Federation
Cytoflavin in the Complex Rehabilitation of Stroke Patients
- Conditions
- Stroke
- Interventions
- Drug: Cytoflavin (Inosine + Nicotinamide + Riboflavin + Succinic Acid)Drug: Placebo
- First Posted Date
- 2023-07-07
- Last Posted Date
- 2024-12-13
- Target Recruit Count
- 196
- Registration Number
- NCT05935787
- Locations
- 🇷🇺
City General Hospital №2, Saint Petersburg, Russian Federation
🇷🇺Saint-Petersburg I.I.Dzanelidze Research Institute of Emergency Medicine, Saint Petersburg, Russian Federation
🇷🇺City Hospital №40 of the Kurortny District, Saint Petersburg, Russian Federation
Remaxol® Used in the Treatment of Patients with Gallstone Disease Complicated with Obstructive Jaundice
- Conditions
- Gallstone DiseaseObstructive Jaundice
- Interventions
- Drug: Remaxol
- First Posted Date
- 2023-07-03
- Last Posted Date
- 2024-12-16
- Target Recruit Count
- 286
- Registration Number
- NCT05928286
- Locations
- 🇷🇺
Krai Clinical Hospital, Barnaul, Russian Federation
🇷🇺Hospital for War Veterans, Kazan, Russian Federation
🇷🇺Pavlov Ryazan State Medical University, Ryazan, Russian Federation
Remaxol® in Patients with Drug-induced Liver Injuries During Cancer Chemotherapy
- Conditions
- CancerDrug Induced Liver Injury
- Interventions
- Drug: Remaxol
- First Posted Date
- 2023-03-29
- Last Posted Date
- 2024-12-16
- Target Recruit Count
- 368
- Registration Number
- NCT05789797
- Locations
- 🇷🇺
North-West Center of Evidence-Based Medicine, Saint Petersburg, Russian Federation
🇷🇺Republican Clinical Cancer Centre, Ufa, Russian Federation
🇷🇺St. Petersburg State Budget-Funded Health Institution City Clinical Cancer Centre, St. Petersburg, Russian Federation
Study of Safety and Efficiency of the Drug Reamberin® in the Intensive Care of Patients with Acute Ethanol Intoxication
- Conditions
- Ethanol Intoxication
- Interventions
- Drug: Reamberin
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2024-12-16
- Target Recruit Count
- 286
- Registration Number
- NCT05715723
- Locations
- 🇷🇺
Buyanov City Clinical Hospital, Moscow, Russian Federation
🇷🇺KORSAKOV Medical Center, Moscow, Russian Federation
🇷🇺Negovsky Research Institute of General Intensive Care Medicine, Moscow, Russian Federation
Cytoflavin in Combination With Reperfusion in Stroke Patients
- Conditions
- Acute Stroke
- Interventions
- Drug: Cytoflavin (succinic acid + inosine + nicotinamide + riboflavin)Drug: Control
- First Posted Date
- 2022-03-28
- Last Posted Date
- 2023-03-20
- Target Recruit Count
- 200
- Registration Number
- NCT05297851
- Locations
- 🇷🇺
Interregional Clinical and Diagnostic Center, Kazan, Russian Federation
🇷🇺City General Hospital №2, Saint Petersburg, Russian Federation
🇷🇺SPb GBUZ "City Hospital №26", Saint Petersburg, Russian Federation